| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |